SUPN - SUPERNUS PHARMACEUTICALS, INC.
IEX Last Trade
36
0.005 0.014%
Share volume: 2,748
Last Updated: Thu 26 Dec 2024 08:30:06 PM CET
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
1.30%
PREVIOUS CLOSE
CHG
CHG%
$36.00
0.01
0.01%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-08 | 2022-11-09 | 2023-03-09 | 2023-05-09 | 2023-08-08 | 2023-11-08 | 2024-02-27 | 2024-05-08 | |
| Total revenue | 170.051 M | 177.353 M | 167.328 M | 153.764 M | 135.563 M | 153.880 M | 164.314 M | 143.644 M | |
| Cost of revenue | 20.457 M | 25.878 M | 22.954 M | 23.460 M | 21.091 M | 19.601 M | 19.627 M | 16.309 M | |
| Gross profit | 149.594 M | 151.475 M | 144.374 M | 130.304 M | 114.472 M | 134.279 M | 144.687 M | 127.335 M | |
| 1.26% | -4.69% | -9.75% | -12.15% | 17.30% | 7.75% | -11.99% | |||
| Operating expenses | 116.861 M | 131.868 M | 91.746 M | 106.809 M | 111.161 M | 105.355 M | 104.629 M | 111.446 M | |
| Selling general and admin | 100.476 M | 112.314 M | 73.972 M | 85.597 M | 86.782 M | 82.700 M | 81.282 M | 86.516 M | |
| Research and development | 16.385 M | 19.554 M | 17.774 M | 21.212 M | 24.379 M | 22.655 M | 23.347 M | 24.930 M | |
| Total expenses | 157.962 M | 178.390 M | 135.398 M | 150.235 M | 152.360 M | 146.198 M | 145.325 M | 147.892 M | |
| 12.93% | -24.10% | 10.96% | 1.41% | -4.04% | -0.60% | 1.77% | |||
| Operating income | 12.089 M | -1.037 M | 31.930 M | 3.529 M | -16.797 M | 7.682 M | 18.989 M | -4.248 M | |
| Ebit | 12.089 M | -1.037 M | 31.930 M | 3.529 M | -16.797 M | 7.682 M | 18.989 M | -4.248 M | |
| Pretax income | 11.324 M | -444.000 K | 35.140 M | 9.017 M | -17.127 M | 9.889 M | 990.000 K | 243.000 K | |
| -103.92% | -8,014.41% | -74.34% | -289.94% | -157.74% | -89.99% | -75.45% | |||
| Income tax | 3.459 M | -2.193 M | 9.659 M | -7.931 M | -16.296 M | 25.865 M | -185.000 K | 119.000 K | |
| Net income basic | 7.865 M | 1.749 M | 25.481 M | 16.948 M | -831.000 K | -15.976 M | 1.175 M | 124.000 K | |
| -77.76% | 1,356.89% | -33.49% | -104.90% | -1,822.50% | 107.35% | -89.45% | |||
| Net income | 7.865 M | 1.749 M | 25.481 M | 16.948 M | -831.000 K | -15.976 M | 1.175 M | 124.000 K | |
| -77.76% | 1,356.89% | -33.49% | -104.90% | -1,822.50% | 107.35% | -89.45% |